Pascal M. Jabbour, MD
Professor, Neurological Surgery
The Angela and Richard T. Clark Distinguished Professor
Division Chief, Neurovascular Surgery & Endovascular Neurosurgery
Contact
909 Walnut Street
2nd Floor
Philadelphia, Pennsylvania 19107
215-955-7000
215-503-7038 fax
Pascal M. Jabbour, MD
Professor, Neurological Surgery
The Angela and Richard T. Clark Distinguished Professor
Division Chief, Neurovascular Surgery & Endovascular Neurosurgery
Education
Medical School
St. Joseph's University, Beirut, Lebanon
Residency
Hotel Dieu de France Hospital (Beirut)
University of Colorado
Thomas Jefferson University
Fellowship
Vascular Neurosurgery ,Thomas Jefferson University Hospital
Publications
- Sphenopalatine Artery Pseudoaneurysm Formation Following Facial Trauma: A case Report and Literature Review
- Onyx Versus Particles for Middle Meningeal Artery Embolization in Chronic Subdural Hematoma
- Mechanical Thrombectomy for Stroke Due to Acute Basilar Artery Occlusion, a Safety and Efficacy Analysis
- 101 30-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis: A Multicenter Propensity-Score Matched Comparison With SAMMPRIS Trial
- In Reply to the Letter to the Editor Regarding: “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
Board Certification
Neurological Surgery
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
Languages
English, French, Arabic
Expertise & Research Interests
Dr. Jabbour is a vascular neurosurgeon who is dually trained in open surgical techniques as well as minimally invasive endovascular surgical techniques. He treats patients with diseases in the blood vessels in their neck, brain, or spinal cord. He also treats pediatric patients with retinoblastoma with selective intra-arterial chemotherapy. Dr. Jabbour is a pioneer in the field of trans-radial access for neurointerventions and has begun to implement the use of robots in endovascular neurosurgery. Dr Jabbour has published more than 500 papers in peer reviewed journals that are based on his clinical research, which has given Jefferson patients access to novel clinical trials for aneurysms and other vascular issues.